V A Memoli

2.4k citations
31 papers · 2.0k indexed · h-index 20

Impact in

Papers in

V A Memoli

31 papers receiving 1.9k citations

Peers

V A Memoli
Comparison fields: 5 of 93
  • Immunology and Allergy 179
  • Oncology 729
  • Rheumatology 341
  • Cell Biology 233
  • Immunology 293
Replace Carmen Bellas with:
Carmen Bellas Spain
Gayle G. Vaday Israel
Rikuo Machinami Japan
Nathalie Bardin France
Pascal Chaubert Switzerland
Hendrik De Raeve Belgium
Gian Marco Tosi Italy
Sophie Dupuis‐Girod France
Yuki Morimoto Japan
Maurizio Lestani Italy
V A Memoli relative to Carmen Bellas Spain Carmen Bellas's profile →
Citations per field
00.5×2.6×
Carmen Bellas · 1×
Citations per year

Countries citing papers authored by V A Memoli

Since Specialization
Citations

This map shows the geographic impact of V A Memoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V A Memoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V A Memoli more than expected).

Fields of papers citing papers by V A Memoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V A Memoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V A Memoli. The network helps show where V A Memoli may publish in the future.

Co-authorship network

The 25 scholars most cited alongside V A Memoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V A Memoli Line = papers co-authored together V A Memoli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2006142
2 20055
3
The combination of in situ hybridization and immunohistochemical analysis: an evaluation of Her2/neu expression in paraffin-embedded breast carcinomas and adjacent normal-appearing breast epithelium.
199737
4 1997187
5 1995150
6 199511
7 19954
8 199539
9 199426
10 19942
11 199352
12 19924
13
Characterization of the ELSV transgenic mouse model of pancreatic carcinoma. Histologic type of large and small tumors.
199216
14
Occurrence of components of fibrinolysis pathways in situ in neoplastic and nonneoplastic human breast tissue.
199128
15 199027
16 199045
17 198984
18
Moab sccl 175 distinguishes small cell carcinoma scc from well differentiated neuroendocrine carcinoma wdnc of lung
19882
19
Neuroendocrine carcinoma of the pancreas diagnosed by aspiration cytology. A case report.
198522
20 198236

About V A Memoli

V A Memoli is a scholar working on Immunology and Allergy, Oncology, Cancer Research, Cell Biology and Genetics, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Cell Adhesion Molecules Research (5 papers), HER2/EGFR in Cancer Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Blood properties and coagulation (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). The work is most often cited by research in Immunology and Allergy (179 citations), Oncology (729 citations), Rheumatology (341 citations), Cell Biology (233 citations) and Immunology (293 citations). V A Memoli has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Victor E. Gould, Klaus E. Kuettner, R. Ilona Linnoila, William H. Warren, Bendicht U. Pauli, Bradley A. Arrick, Thérèse A. Stukel, Leslie I. Gold, B Kudryk and W Kisiel. Their work appears in journals such as The Journal of Cell Biology, JNCI Journal of the National Cancer Institute, Blood Coagulation & Fibrinolysis, Journal of Clinical Oncology and Neuropeptides.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026